Intellia Therapeutics, Inc. (LON:0JBU)
London · Delayed Price · Currency is GBP · Price in USD 10.54
+0.33 (3.23%)
At close: Aug 22, 2025
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of 834.14 million as of August 22, 2025. Its market cap has decreased by -48.39% in one year.
Market Cap
834.14M
Enterprise Value
444.20M
Revenue
38.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.54
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from 537.16M to 834.14M, an increase of 55.29%. That is a compound annual growth rate of 4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 834.14M | -12.06% |
| Dec 31, 2024 | 948.58M | -55.75% |
| Dec 29, 2023 | 2.14B | -13.15% |
| Dec 30, 2022 | 2.47B | -62.02% |
| Dec 31, 2021 | 6.50B | 152.49% |
| Dec 31, 2020 | 2.57B | 375.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 186.83B |
| GSK plc | 60.14B |
| Haleon | 32.80B |
| Smith & Nephew | 12.08B |
| ConvaTec Group | 4.96B |
| Hikma Pharmaceuticals | 4.03B |
| HUTCHMED (China) | 2.04B |
| Oxford Nanopore Technologies | 2.03B |